Stablepoint Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Stablepoint Partners's AMGN Position: Q2 2026 in Review
Stablepoint Partners increased its Amgen (AMGN) stake by 0.57% in Q2 2026, buying an estimated $60.2K and bringing the position to 31,144 shares worth $11.3M. The position accounts for 1.56% of the portfolio, ranked #6.
Stablepoint Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stablepoint Partners held 31,144 shares of Amgen worth $11.3M as of Q2 2026.
- Stablepoint Partners bought 176 Amgen shares in Q2 2026, an estimated $60.2K.
- Amgen made up 1.56% of Stablepoint Partners's portfolio in Q2 2026, its #6 holding.
- Stablepoint Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.